|
Klebsiella species
(K. pneumoniae, K. oxytoca, K. ozaenae and K.
rhinoscleromatis)
Read the Chapter
Sliding Table of
Contents on the left of the screen
Tables and
Figures
Table 1.
Susceptibility of K. pneumoniae to Antimicrobial Agents.
Table 1a.
Susceptibility of K. pneumoniae to Antimicrobial Agents (continued)
Table 2.
Susceptibility of ESBL Producing K. pneumoniae to Antimicrobial Agents.
Table 2a.
Susceptibility of ESBL Producing K. pneumoniae to Antimicrobial Agents
(continued)
Table 3:
Mechanisms of Resistance of Klebsiella Pneumoniae to Commonly Used
Antibiotics
Table 4:
Treatment and Clinical Outcome of Patients with Serious Infections Due to
K. Ozaenae
Table 5:
Empiric Antibiotic Therapy for Serious Infections Caused by Non-ESBL Producing
K. pneumoniae Pending Knowledge of In Vitro Susceptibilities
Table 6:
Treatment Options for ESBL Producing K. pneumoniae Infections
Vignettes
Review Article: Pitout JD. Enterobacteriaceae Producing ESBLs in the Community:
Are They a Real Threat? Infect Med 2007;24:57-65.
Review Article: Golnaz J, Zuravleff J.
Retinitis and Endophthalmitis.
2007.
Review Article:
Efflux Pumps as a Mechanism
of Antimicrobial Resistance. 2008
Review Article:
Paterson DL. Antibiotic Therapy for Klebsiella pneumoniae Bacteremia:
Implications of Production of Extended-Spectrum beta-Lactamases. Clin Infect
Dis. 2004.
Review Article: Raad, I., Hanna, H. and
Maki, D. Intravascular Catheter-related Infections: Advances in Diagnosis,
Prevention and Management. The LANCET Infectious Diseases 2007; Vol.7, Issue 10,
645-657.
Review Article: Bush K, et al.
MiniReview: Updated Functional Classification of β-lactamases.
Antimicrob Agents Chemother 2010;54:969-976.
Falagas ME, Kastoris AC, et al.
Fosfomycin for the Treatment of Multidrug-Resistant,
Including Extended-Spectrum beta-Lactamase Producing, Enterobacteriaceae
Infections: A Systematic Review. Lancet Infect Dis. 2010
Jan;10:43-50.
Ko WC,
Paterson DL, et al.
Community-Acquired Klebsiella pneumoniae
Bacteremia: Global Differences in Clinical Patterns.
Emerg Infect Dis 2002;8:160-166.
Yu VL, et al.
Virulence Characteristics of Klebsiella and
Clinical Manifestations of K. pneumoniae Bloodstream Infections. Emerg Infect Dis 2007;13:986-993.
Paterson DL, et al. International
Prospective Study of Klebsiella pneumoniae Bacteremia: Implications of
Extended-Spectrum ß-Lactamase
Production in Nosocomial Infections.
Ann Intern Med 2004;39(1):31-37.
Lee, SS et al.
Predictors of Septic Metastatic Infection and Mortality
Among Patients with Klebsiella Pneumoniae Liver Abscess.
Clin Infect Dis. 2008 Sep
1;47(5):642-50.
Authors
David L. Paterson, M.D., 
Kris
L. K. Siu, PhD,
Feng Yee Chang, M.D.
First Edition (1998):
David L. Paterson and Gordon M. Trenholme
|
www.antimicrobe.org